The Short Answer
This page lists the liver transplant & hpb hospitals in our directory offering Pulmonary Fibrosis in Chennai, India, including Apollo Hospitals, Greams Road, Gleneagles Global Hospital, Dr. Rela Institute and Medical Centre, SIMS Hospital and others. Each listing links through to the hospital's full profile page.
Ask us about pulmonary fibrosis in Chennai, India
Share a few details and our care coordination team will get back to you with next steps.
Top Hospitals for Pulmonary Fibrosis in Chennai, India
🇮🇳 Apollo Hospitals, Greams Road
Chennai, India 4.7 (125 reviews) 560 beds
Why consider this hospital?
4.7/5 rating from 125 reviews560 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Patients considering pulmonary fibrosis can be cared for by Apollo Hospitals, Greams Road's care team in Chennai, India, from initial consultation through recovery. Apollo Hospitals, Greams Road, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing pulmonary fibrosis.
4.7/5
Rating
1983
Established
560
Beds
Chennai, India
Location
🇮🇳 Gleneagles Global Hospital
Chennai, India 4.7 (112 reviews) 1,000 beds
Why consider this hospital?
4.7/5 rating from 112 reviews1,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationJCI — Joint Commission International accreditation
Patients considering pulmonary fibrosis can be cared for by Gleneagles Global Hospital's care team in Chennai, India, from initial consultation through recovery. Gleneagles Global Hospital, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing pulmonary fibrosis.
4.7/5
Rating
1999
Established
1,000
Beds
Chennai, India
Location
🇮🇳 Dr. Rela Institute and Medical Centre
Chennai, India 4.7 (108 reviews) 450 beds
Why consider this hospital?
4.7/5 rating from 108 reviews450 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
Patients considering pulmonary fibrosis can be cared for by Dr. Rela Institute and Medical Centre's care team in Chennai, India, from initial consultation through recovery. Dr. Rela Institute and Medical Centre, accredited by NABH, NABL, follows recognised patient-safety and quality-of-care standards when performing pulmonary fibrosis.
4.7/5
Rating
2018
Established
450
Beds
Chennai, India
Location
🇮🇳 SIMS Hospital
Chennai, India 4.6 (20 reviews) 345 beds
Why consider this hospital?
4.6/5 rating from 20 reviews345 beds
Specialties & Accreditation
Cardiac SurgeryNeurosciencesTransplantOrthopedicsGastroenterology
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationJCI — Joint Commission International accreditation
Patients considering pulmonary fibrosis can be cared for by SIMS Hospital's care team in Chennai, India, from initial consultation through recovery. SIMS Hospital, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing pulmonary fibrosis.
4.6/5
Rating
1970
Established
345
Beds
Chennai, India
Location
🇮🇳 Sankara Nethralaya
Nungambakkam, Chennai, India 4.4 (220 reviews) 200 beds
Why consider this hospital?
4.4/5 rating from 220 reviews200 beds
Specialties & Accreditation
OphthalmologyRetina SurgeryCornea TransplantGlaucomaPediatric Ophthalmology
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
Patients considering pulmonary fibrosis can be cared for by Sankara Nethralaya's care team in Nungambakkam, Chennai, India, from initial consultation through recovery. Sankara Nethralaya, accredited by NABH, NABL, follows recognised patient-safety and quality-of-care standards when performing pulmonary fibrosis.
4.4/5
Rating
1978
Established
200
Beds
Nungambakkam, Chennai, India
Location
🇮🇳 Apollo First Med Hospitals, Kilpauk
Kilpauk, Chennai, India 4.4 (76 reviews) 80 beds
Why consider this hospital?
4.4/5 rating from 76 reviews80 beds
Specialties & Accreditation
Cardiac SciencesOrthopedicsNeurologyOncologyGastroenterology
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationJCI — Joint Commission International accreditation
Patients considering pulmonary fibrosis can be cared for by Apollo First Med Hospitals, Kilpauk's care team in Kilpauk, Chennai, India, from initial consultation through recovery. Apollo First Med Hospitals, Kilpauk, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing pulmonary fibrosis.
4.4/5
Rating
2002
Established
80
Beds
Kilpauk, Chennai, India
Location
🇮🇳 MIOT International
Manapakkam, Chennai, India 4.4 (200 reviews) 1,000 beds
Why consider this hospital?
4.4/5 rating from 200 reviews1,000 beds
Specialties & Accreditation
OrthopedicsCardiac SurgeryNeurosciencesTransplantOncology
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditationJCI — Joint Commission International accreditation
Patients considering pulmonary fibrosis can be cared for by MIOT International's care team in Manapakkam, Chennai, India, from initial consultation through recovery. MIOT International, accredited by NABH, NABL, JCI, follows recognised patient-safety and quality-of-care standards when performing pulmonary fibrosis.
4.4/5
Rating
1999
Established
1,000
Beds
Manapakkam, Chennai, India
Location
🇮🇳 MGM Healthcare
Chennai, India 3.7 (34 reviews) 400 beds
Why consider this hospital?
3.7/5 rating from 34 reviews400 beds
Specialties & Accreditation
Cardiac SurgeryNeurosciencesTransplantCancer CareOrthopedics
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationJCI — Joint Commission International accreditation
Patients considering pulmonary fibrosis can be cared for by MGM Healthcare's care team in Chennai, India, from initial consultation through recovery. MGM Healthcare, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing pulmonary fibrosis.
3.7/5
Rating
1970
Established
400
Beds
Chennai, India
Location
Top Liver Transplant & HPB Doctors in Chennai, India
FeaturedDr. Arul Kumar S
MBBS, MS in General Surgery, Fellowship in HPB Surgery, Fellowship in Liver Transplantation
Associate Consultant — Surgical Gastroenterology · Specialty: Hepato-Pancreato-Biliary (HPB) Surgeon
Rela Hospital Chennai, India18+ Years experience
Why consider this doctor?
- 18+ years of experience in Hepato-Pancreato-Biliary (HPB) Surgeon
- Associate Consultant, Department of Surgical Gastroenterology and HPB Surgery, Rela Hospital, Chennai
- Training in HPB Surgery, Christian Medical College, Vellore
Expertise & Procedures
- Live donor liver transplantation
- Deceased donor liver transplant
- Hilar cholangiocarcinoma resection
- Whipple procedure (pancreaticoduodenectomy)
- Complex liver resections
Hepato-Pancreato-Biliary (HPB) Surgeon Experience: 18+ YearsHospital Affiliation: Rela HospitalHospital accreditation: NABH, NABL
Dr. Dinesh Jothimani
MBBS, MRCP (UK), CCT in Hepatology, Gastroenterology & General Medicine, FRCP (Glasgow)
Director — Hepatology, Gastroenterology & Hepatobiliary · Specialty: Hepatologist
Dr. Rela Institute & Medical Centre Chennai, India19+ Years experience
Why consider this doctor?
- 19+ years of experience in Hepatologist
- Director, Hepatology, Gastroenterology & Hepatobiliary — Dr. Rela Institute & Medical Centre, Chennai
- Consultant Hepatologist and Liver Transplant Physician — Global Hospitals, Chennai
Expertise & Procedures
- ERCP (Endoscopic Retrograde Cholangiopancreatography)
- Liver Transplant Assessment and Management
- Hepatic Biopsy and Fibroscan
- Endoscopic Variceal Ligation
- Management of Acute Liver Failure
Hepatologist Experience: 19+ YearsHospital Affiliation: Dr. Rela Institute & Medical CentreHospital accreditation: NABH, NABL
Dr. Gomathy Narasimhan
MBBS, MS, ASTS Fellowship in Transplant Surgery, GMHE
Senior Consultant — Liver and Renal Transplant Surgery & Surgical Gastroenterology · Specialty: Liver Transplant Surgeon
Rela Hospital Chennai, India20+ Years experience
Why consider this doctor?
- 20+ years of experience in Liver Transplant Surgeon
- Senior Consultant — Liver and Renal Transplant Surgery & Surgical Gastroenterology, Rela Hospital, Chennai, Present
- ASTS Fellowship in Transplant Surgery, Baylor University Medical Center, Dallas, Texas, USA, 2006
Expertise & Procedures
- Adult liver transplantation
- Pediatric liver transplant
- Living donor kidney transplant
- Combined liver-kidney transplant
- Multivisceral transplant
Liver Transplant Surgeon Experience: 20+ YearsHospital Affiliation: Rela HospitalHospital accreditation: NABH, NABL
Dr. Jasper Sandeep Rajasekar
MBBS, MS, MCh, MRCS
Associate Consultant — Surgical Gastroenterology · Specialty: Hepatobiliary & Liver Transplant Surgeon
Rela Hospital Chennai, India11+ Years experience
Why consider this doctor?
- 11+ years of experience in Hepatobiliary & Liver Transplant Surgeon
- Associate Consultant, Surgical Gastroenterology, Rela Hospital, Chennai — Present
- Liver Transplantation Unit Member, Rela Hospital, Chennai — 2016–Present
Expertise & Procedures
- Living donor liver transplantation (LDLT)
- Deceased donor liver transplantation
- Pediatric liver transplantation
- Hepatocellular carcinoma resection
- Whipple procedure (pancreaticoduodenectomy)
Hepatobiliary & Liver Transplant Surgeon Experience: 11+ YearsHospital Affiliation: Rela HospitalHospital accreditation: NABH, NABL
Dr. Joy Varghese
MBBS, MD, DM (Gastroenterology), PhD, Fellowship in Liver Transplantation
Director of Hepatology & Transplant Hepatology — Gastroenterology & Hepatobiliary · Specialty: Hepatologist & Liver Transplant Physician
Gleneagles HealthCity Chennai Chennai, India25+ Years experience
Why consider this doctor?
- 25+ years of experience in Hepatologist & Liver Transplant Physician
- Director of Hepatology & Transplant Hepatology – Gleneagles HealthCity, Chennai, India – Present
- Program Director, Liver Transplant Society of India (LTSI) Fellowship in Transplant Hepatology – Gleneagles HealthCity, Chennai – Present
Expertise & Procedures
- Orthotopic Liver Transplantation
- Living Donor Liver Transplantation
- Liver Biopsy
- Endoscopic Variceal Ligation
- Therapeutic Plasma Exchange for Liver Diseases
Hepatologist & Liver Transplant Physician Experience: 25+ YearsHospital Affiliation: Gleneagles HealthCity ChennaiHospital accreditation: NABH, JCI
Dr. Kumar Palaniappan
MBBS, DNB General Surgery, DNB Surgical Gastroenterology, Fellowship in Liver Transplantation & HPB Surgery
Clinical Lead — Laparoscopy Liver Surgery, Surgical Gastroenterology · Specialty: Hepatobiliary & Liver Transplant Surgeon
Rela Hospital Chennai, India20+ Years experience
Why consider this doctor?
- 20+ years of experience in Hepatobiliary & Liver Transplant Surgeon
- Clinical Lead – Laparoscopy Liver Surgery, Senior Consultant Abdominal Trauma, HPB Surgery & Liver Transplantation, Rela Hospital, Chennai – Present
- Senior Consultant Hepatobiliary & Liver Transplant Surgery, Gleneagles Global Hospitals, Chennai
Expertise & Procedures
- Liver Transplantation (Living & Deceased Donor)
- Laparoscopic Liver Resection
- Hepatic Tumor Surgery
- Whipple Procedure (Pancreaticoduodenectomy)
- Gastrectomy
Hepatobiliary & Liver Transplant Surgeon Experience: 20+ YearsHospital Affiliation: Rela HospitalHospital accreditation: NABH, NABL
Our Methodology
How we selected these hospitals
A hospital appears on this page when Liver Transplant & HPB is among its listed specialties and it is located in Chennai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
What To Look For
How to Select the Best Hospital for Pulmonary Fibrosis in Chennai, India?
Choosing the right hospital for pulmonary fibrosis is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:
International Accreditation
Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.
Specialization
Check that the hospital's listed specialties actually include liver transplant & hpb rather than only general care.
Capacity and Track Record
Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.
Transparent Costs
Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.
Clinical Overview
Understanding Pulmonary Fibrosis
Pulmonary fibrosis treatment in India and the UAE offers internationally accredited antifibrotic therapy, multidisciplinary ILD (interstitial lung disease) programs, and comprehensive lung transplant evaluation — at a fraction of Western costs.
5–10 days (initial evaluation and stabilization); 14–21 days (if lung transplant is performed)
Hospital Stay
2–4 weeks for antifibrotic therapy initiation and stabilization; 8–12 weeks minimum post-lung transplant before intercontinental flight clearance
Total Stay in Country (Fit-to-Fly)
60–75% disease stabilization on antifibrotic therapy; 85–90% 1-year post-transplant survival at high-volume centers
Success Rate
Clinical Overview
- Pulmonary fibrosis — most critically in its idiopathic form (IPF) — is a progressive, irreversible scarring of lung parenchyma driven by aberrant epithelial injury-repair cycles, fibroblast proliferation, and excess extracellular matrix deposition.
- As fibrosis advances, alveolar architecture is destroyed, gas exchange efficiency falls, and patients develop exertional hypoxemia, a dry non-productive cough, and progressively restrictive ventilatory physiology.
- Median survival from diagnosis without treatment is historically 3–5 years, though disease trajectory varies considerably — a minority follow a slowly progressive course, while others experience acute exacerbations that carry a 50–80% in-hospital mortality.
Who is a Candidate?
- CONFIRMED IPF DIAGNOSIS: Multidisciplinary ILD board consensus based on HRCT UIP pattern (± surgical lung biopsy via VATS) after exclusion of secondary causes (connective tissue disease, drug toxicity, hypersensitivity pneumonitis)
- ANTIFIBROTIC THERAPY CANDIDATES: FVC ≥50% predicted, DLCO ≥30% predicted, confirmed UIP/probable UIP on HRCT, NYHA/MRC dyspnea grade II–III, absence of advanced hepatic impairment (nintedanib) or severe photosensitivity contraindication (pirfenidone)
- TRANSPLANT EVALUATION CANDIDATES: Progressive disease despite ≥6 months of antifibrotic therapy, FVC <80% predicted with ≥10% relative decline over 12 months, DLCO <40% predicted, 6-minute walk test desaturation below SpO₂ 88%, or acute exacerbation requiring hospitalization
- REQUIRED DIAGNOSTIC WORKUP BEFORE TRAVEL: HRCT chest (thin-slice ≤1.5 mm), full pulmonary function tests (spirometry, plethysmography, DLCO), 6-minute walk test with oximetry, echocardiography (to assess pulmonary hypertension — a key modifier of transplant candidacy), CT pulmonary angiography or V/Q scan (to exclude chronic thromboembolic disease), standard metabolic panel, LFTs, renal function, and ANA/RF/anti-CCP/anti-Scl70 autoimmune panel
- +3 more
Treatment Options & Approaches
- ANTIFIBROTIC PHARMACOTHERAPY Nintedanib (Ofev®): A triple tyrosine kinase inhibitor administered orally at 150 mg twice daily with food.
- It inhibits PDGFR-α/β, FGFR-1/2/3, and VEGFR-1/2/3 — receptors that mediate fibroblast proliferation, differentiation, and migration.
- In the INPULSIS trials, nintedanib reduced annual FVC decline by 50% (approximately 50 mL/year vs. 200 mL/year on placebo).
Recovery
- PHASE 1 — PRE-ARRIVAL COORDINATION (2–4 weeks before travel) GAF Healthcare's medical coordinators review all existing diagnostic records (HRCT, PFTs, bronchoscopy/biopsy reports, echocardiography) via a secure digital portal.
- The in-house medical team prepares a provisional treatment pathway — antifibrotic initiation vs. transplant evaluation — and selects the appropriate partner center.
- The patient receives a pre-travel checklist specifying required investigations to be completed at home to avoid duplication and unnecessary cost. e-Medical visa (India) or UAE entry visa documentation is prepared in parallel.
Risks to be aware of
- Pulmonary fibrosis treatment carries a distinct risk profile at each stage of the care pathway, and patients must receive a fully transparent risk discussion before travel.
Why GAF Healthcare
- GAF Healthcare provides an integrated medical tourism support infrastructure that addresses every non-clinical barrier to treatment access for international patients.
Common questions about Pulmonary Fibrosis
What is the cost of Pulmonary Fibrosis Treatment (Antifibrotic Therapy & Transplant Evaluation) in India vs. the UAE?
The total cost depends on the specific treatment pathway — antifibrotic therapy initiation with full ILD workup, or lung transplant evaluation and transplantation.
In India, the cost for a comprehensive ILD workup and antifibrotic therapy initiation (including hospital admission, all diagnostics — HRCT, PFTs, echocardiography, right heart catheterization where indicated — pulmonary rehabilitation, and 2-week supervised medication titration) ranges from USD 3,500 to USD 8,000. A full bilateral lung transplant in India, including pre-transplant evaluation, surgery, ICU care, and 3-week hospitalization, typically costs USD 28,000 to USD 45,000 all-inclusive.
In the UAE (Dubai/Abu Dhabi), equivalent ILD workup and antifibrotic initiation costs range from USD 7,000 to USD 15,000, while a bilateral lung transplant ranges from USD 55,000 to USD 90,000, reflecting the premium infrastructure, nursing ratios, and luxury accommodation standards of UAE hospitals.
India is typically 40–60% less expensive than the UAE across all stages of care. Both destinations offer care at JCI-accredited hospitals (India additionally with NABH accreditation; UAE with DHA/MOH regulatory oversight), ensuring clinical quality comparable to Western European or North American centers. GAF Healthcare provides transparent, itemized cost estimates before any commitment is made.
How long do I need to stay in India or the UAE before I am fit to fly home?
The required in-country stay depends on your treatment pathway:
ANTIFIBROTIC THERAPY INITIATION: Most patients require 2–4 weeks in-country. The first 3 days are for diagnostic confirmation and MDT review, followed by 10–14 days of supervised medication titration to confirm tolerability (GI side effects for both nintedanib and pirfenidone typically peak and stabilize within the first 2 weeks). A fit-to-fly assessment at Day 14–21 evaluates SpO₂ stability at rest and on ambulation, treatment tolerance, and confirms that the patient has access to ongoing antifibrotic prescriptions and a pulmonologist in their home country. Most patients with stable disease at this point can fly safely in standard commercial class with or without ambulatory oxygen, depending on their baseline DLCO and resting SpO₂.
LUNG TRANSPLANT EVALUATION ONLY (NO TRANSPLANT PERFORMED): 2–3 weeks for the complete organ-system workup, MDT listing conference, and listing decision. Most patients are medically stable enough to fly home within 3–4 weeks pending no acute deterioration during evaluation.
BILATERAL LUNG TRANSPLANTATION: Minimum in-country stay is 8–10 weeks post-surgery. The first 3–4 weeks are spent as an inpatient (ICU followed by step-down ward). After hospital discharge, outpatient visits continue weekly for the next 4–6 weeks for immunosuppression monitoring, surveillance bronchoscopy (at 4–6 weeks), and spirometry. Intercontinental flights (>8 hours) are generally cleared at 8–10 weeks post-transplant, contingent on stable graft function, no active rejection or infection, independence from supplemental oxygen at rest, and a confirmed post-transplant follow-up plan with a pulmonologist in the home country. GAF Healthcare provides the treating airline with a standard medically fit-to-fly certificate signed by the transplant team.
What is the success rate of Pulmonary Fibrosis Treatment in India and the UAE?
Success in pulmonary fibrosis treatment is defined differently at each stage of the care pathway, and it is important for patients to have realistic, evidence-based expectations.
ANTIFIBROTIC THERAPY: Both approved antifibrotic agents (nintedanib and pirfenidone) reduce the annual rate of FVC decline by approximately 50% compared to the natural disease course. In clinical terms, approximately 60–75% of appropriately selected patients achieve disease stabilization (defined as <10% relative FVC decline over 12 months) in the first year of treatment. Neither agent reverses existing fibrosis or improves lung function; the goal is slowing progression and reducing the risk and frequency of acute exacerbations. GAF Healthcare partner centers achieve these outcomes through rigorous patient selection, structured tolerability management (dose optimization rather than premature discontinuation), and integration of pulmonary rehabilitation, which independently improves functional capacity and quality of life.
LUNG TRANSPLANTATION: At high-volume centers in India and the UAE — defined as centers performing ≥20 lung transplants per year with established ISHLT registry participation — outcomes closely parallel international benchmarks. The 1-year post-lung transplant survival rate is 85–90%, the 3-year survival is approximately 70–75%, and the 5-year survival is 55–65% for IPF recipients. Bilateral sequential lung transplantation (the preferred procedure for IPF) confers a meaningful survival advantage over single-lung transplantation. The primary determinants of outcome are center volume and experience, surgical technique, primary graft dysfunction prevention (optimal organ preservation and ischemic time minimization), and the quality of post-transplant immunosuppression management and infection surveillance — all of which are rigorously standardized at GAF Healthcare's partner transplant centers.
Related pages
Related procedures
Other cities
How GAF Healthcare Assists in Choosing the Best Hospital for Pulmonary Fibrosis in Chennai, India
Discover the Top Hospitals for Pulmonary Fibrosis in Chennai, India
This page lists 8 accredited liver transplant & hpb hospitals in Chennai, India, so you can compare accreditation, specialties and bed capacity in one place.
Support When You Need It Most
Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.
Transparent, All-Inclusive Costs
We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.
Visa, Travel and Stay Coordination
Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.
Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.
Patient Success Story
Iraqi Family's Journey: Baby Ibrahim's Life-Saving Heart Surgery in India
Common Questions
Frequently asked questions about pulmonary fibrosis in Chennai, India
How many liver transplant & hpb hospitals are listed in Chennai, India?
8 hospitals in our Chennai, India directory are currently listed for liver transplant & hpb including Pulmonary Fibrosis.
How do you choose which hospitals to list?
A hospital appears on this page when Liver Transplant & HPB is among its listed specialties and it is located in Chennai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Are there liver transplant & hpb hospitals for this in other India cities?
See the "Hospitals in other cities" links on this page for the full India list.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including JCI, NABH, NABL — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for pulmonary fibrosis?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
Next Step
Share your medical reports with us and our team will recommend a hospital and treatment plan for pulmonary fibrosis in Chennai, India.
Contact us to report an inaccuracy on this page.